| Views | |
|---|---|
| Informed consent and trial prioritization for clinical studies during the COVID-19 pandemic. Stakeholder experiences and viewpoints | 29 |
| February 2025 | March 2025 | April 2025 | May 2025 | June 2025 | July 2025 | August 2025 | |
|---|---|---|---|---|---|---|---|
| Informed consent and trial prioritization for clinical studies during the COVID-19 pandemic. Stakeholder experiences and viewpoints | 0 | 0 | 0 | 0 | 0 | 28 | 1 |
| Views | |
|---|---|
| 2024_Weigold_etal.pdf | 5 |
